ISB News

ISB Artwork Featured On Cover of Nature Biotechnology

The Institute for Systems Biology and Arivale “Pioneer 100 Study” is featured on the cover of August’s Nature Biotechnology. The artwork was created by ISB’s Associate Director of Communications Allison Kudla in collaboration with contributing author John C. Earls, software engineer in the Hood-Price Lab.

About the cover: A subset of statistically significant correlations are extruded in three-dimensional space. Price et al. describe the integration of whole genome sequences; clinical tests, metabolomes, proteomes, and microbiomes at three time points; and regular quantified self-measurements for 108 individuals over 9 months. They obtain thousands of cross-sectional interomic correlations, each represented by a line in the circular figure, to better understand health and disease. Image credit: Allison Kudla, John C. Earls (Institute for Systems Biology)

Recent Articles

  • COVID-19 Vaccines and Boosters Are Essential for Maternal-Fetal Health

    In light of the recent FDA and CDC decision to approve two updated messenger RNA COVID-19 booster shots, it is imperative to alert the pregnant population of the importance and effectiveness of these vaccines and boosters. 

  • 2023 ISB Virtual Microbiome Series

    2023 ISB Virtual Microbiome Series Registration Now Open!

    On October 11-13, 2023, ISB will host a virtual course and symposium on how the ecology of our guts protects us from pathogens. Both events are virtual and free. The intended audience for these events are graduate students, postdocs, principal investigators, industry scientists, educators, clinicians, or any other variety of microbiome-curious person from across the globe.

  • Baliga Postdoctoral Fellow Training

    Genetic Tools Probe Microbial Dark Matter

    ISB researchers Nitin Baliga, Serdar Turkarslan, Mario Arrieta-Ortiz and Yaqiao Li collaborated with the University of Washington to present the first glimpse of the molecular mechanisms behind the unusual lifestyle of a group of tiny microbes called Patescibacteria. The breakthrough was made possible by the discovery of a way to genetically manipulate these bacteria, an advance that has opened a world of possible new research directions.